Assessment of quality of markers of myocardial damage using sigmametry
https://doi.org/10.33667/2078-5631-2020-5-28-29
Abstract
The purpose. To evaluate study quality markers of myocardial damage using Sigmametry.
Materials and methods. The study was conducted in a Federal Centre for Cardiovascular Surgery. Data were collected in 2017–2018. Daily there controlled the following indicators: high-sensitivity troponin T, myoglobin, the MB fraction of creatine phosphokinase. The study was performed on an automatic immunochemical electrochemiluminescence analyzer cobas e411. The sigmametry values were calculated using CV (coefficient of variation), systematic error (bias), and total analytical error (TEmax).
Results. The analysis of the quality of laboratory studies using the calculation of sigma values in 2017 revealed: sigma values less than 4 are noted in the study of the second level of the control material for highly sensitive troponin T, at the same time in the study of the first level of the control material sigma values more than 4 and amounted to 6.26. Analysis of the quality of laboratory studies in 2018, showed the following: the values of sigma is less than 4 it is noted in the study of the first level of the control material at a fraction of MB – creatine phosphokinase, at the same time in the study of level 2 control material values of sigma greater than 4, and amounted to 4.14.
Conclusions. Оn the basis of sigmametry (calculation of sigma values) changes in the tactics of intralaboratory analysis were held, what allowed to improve the quality of laboratory studies.
About the Authors
O. V. PetrovaRussian Federation
Astrakhan
D. K. Tverdokhlebova
Russian Federation
Astrakhan
O. I. Murygina
Russian Federation
Astrakhan
D. M. Nikulina
Russian Federation
Astrakhan
References
1. Арефьева И. А., Федорова М. М., Мошкин А. В. Планирование аналитического качества количественных лабораторных исследований с использованием коммерческих контрольных материалов. Методические рекомендации. M.: Триада. 2013.
2. Дымова О. В. Современные биомаркеры в кардиологии. Медицинский совет. 2018; № 16: 118–123.
3. Калачева О. С., Плеханова О. С. Установка целей по качеству: вопросы выбора требований. Лабораторная служба. 2018; 7 (1): 51–54.
4. Константинов Б. А., Базылев В. В., Белов Ю. В., Кизыма А. Г. Принципы оценки риска развития кардиальных осложнений у больных перед операциями на периферических сосудах и брюшном отделе аорты. Кардиология и сердечно-сосудистая хирургия. 2008; № 1 (1): 27–33.
5. Hens K., Berth M., Armbruster D., Westgard S. Sigma metrics used to assess analytical quality of clinical chemistry assays: importance of the allowable total error (TEa) target. Clin Chem Lab Med. 2014; 52: 973–80.
6. Nanda S. K., Ray L. Quantitative application of sigma metrics in medical biochemistry. J Clin Diagn Res. 2013; 7: 2689–91.
7. Singh B., Goswami B., Gupta V. K., Chawla R., Mallika V. Application of sigma metrics for the assessment of quality assurance in clinical biochemistry laboratory in India: a pilot study. Ind J Clin Biochem. 2011; 26: 131–5.
Review
For citations:
Petrova O.V., Tverdokhlebova D.K., Murygina O.I., Nikulina D.M. Assessment of quality of markers of myocardial damage using sigmametry. Medical alphabet. 2020;(5):28-29. (In Russ.) https://doi.org/10.33667/2078-5631-2020-5-28-29